• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Displaying 54-68 of 759 results

No. 23 ORDER Directing the Parties shall file supplementary briefs, and shall be no longer than (3) ...

Document TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC. et al v. DEVA HOLDING A.S., 2:24-cv-04404, No. 23 (D.N.J. Aug. 5, 2024)
This matter comes before the Court on the motion to dismiss by Defendant Deva Holding A.S.
The statute, 35 U.S.C. § 271(e) (emphasis added), states: (2) It shall be an act of infringement to submit— (A) an application under section 505(j) of the Federal Food, Drug, and Cosmetic Act [21 USCS § 355(j)] or described in section 505(b)(2) of such Act [21 USCS § 355(b)(2)] for a drug claimed in a patent or the use of which is claimed in a patent ...
The parties shall file supplementary briefs on this question: what is the definition of “drug” in the context of this statutory provision?
Briefs shall be no longer than three pages and shall be submitted simultaneously by August 19, 2024.
cite Cite Document

No. 49 OPINION

Document EBIN NEW YORK, INC. v. KISS NAIL PRODUCTS, INC. et al, 2:23-cv-02369, No. 49 (D.N.J. Mar. 28, 2024)
None of the conditions warranting dismissal with prejudice are present here.
cite Cite Document

No. 252 OPINION AND ORDER

Document GW RESEARCH LIMITED v. TEVA PHARMACEUTICALS, INC. et al, 2:23-cv-00018, No. 252 (D.N.J. Jan. 11, 2024)
Log in to see more
cite Cite Document

No. 73 OPINION AND ORDER

Document NOVAPLAST CORPORATION v. INPLANT, LLC et al, 2:20-cv-07396, No. 73 (D.N.J. Jul. 26, 2023)
Log in to see more
cite Cite Document

No. 24 CONSENT ORDER EXTENDING TIME TO ANSWER through 7/21/2023; vacating 2/2/2023 entry of default

Document DAYS INNS WORLDWIDE, INC. v. AVST HOSPITALITY, LLC et al, 2:22-cv-01935, No. 24 (D.N.J. Jul. 10, 2023)
Log in to see more
cite Cite Document

No. 1 COMPLAINT against IDEAVILLAGE PRODUCTS CORP. ( Filing and Admin fee $ 405 receipt number ANJDC-15851069) ...

Document CURELIFE CO., LTD. et al v. IDEAVILLAGE PRODUCTS CORP., 2:24-cv-10910, No. 1 (D.N.J. Dec. 4, 2024)
Complaint
Log in to see more
cite Cite Document

No. 126 MOTION to Seal Document 54 Declaration,,,,, 83 Letter,, 33 Declaration,, 62 Reply Brief to ...

Document INCYTE CORPORATION et al v. SUN PHARMACEUTICAL INDUSTRIES LTD. et al, 2:24-cv-06944, No. 126 (D.N.J. Oct. 22, 2024)
Motion to Seal
Log in to see more
cite Cite Document

No. 37 Application and Proposed Order for Clerk's Order to extend time to answer as to Extending time ...

Document TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC. et al v. DEVA HOLDING A.S., 2:24-cv-04404, No. 37 (D.N.J. Sep. 18, 2024)
Motion to Extend Time
Log in to see more
cite Cite Document

No. 36 ANSWER to Complaint , Separate Defenses and, COUNTERCLAIM against NORTON (WATERFORD) LTD., ...

Document TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC. et al v. DEVA HOLDING A.S., 2:24-cv-04404, No. 36 (D.N.J. Sep. 11, 2024)
Answer
Log in to see more
cite Cite Document

No. 25 BRIEF in Opposition filed by All Plaintiffs re 11 MOTION to Dismiss The Complaint for Lack ...

Document TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC. et al v. DEVA HOLDING A.S., 2:24-cv-04404, No. 25 (D.N.J. Aug. 19, 2024)
Log in to see more
cite Cite Document

No. 60 Letter from Liza M. Walsh to the Hon

Document TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC. et al v. DEVA HOLDING A.S., 2:24-cv-04404, No. 60 (D.N.J. Mar. 6, 2025)
Log in to see more
cite Cite Document

No. 58 Letter from Liza M. Walsh to the Hon

Document TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC. et al v. DEVA HOLDING A.S., 2:24-cv-04404, No. 58 (D.N.J. Mar. 5, 2025)
Log in to see more
cite Cite Document

No. 57 Teva Branded Pharmaceutical Products R&D LLC, Norton (Waterford) Ltd., and Teva Pharmaceuticals ...

Document TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC. et al v. DEVA HOLDING A.S., 2:24-cv-04404, No. 57 (D.N.J. Feb. 21, 2025)
Log in to see more
cite Cite Document

No. 1 COMPLAINT against SUN PHARMACEUTICAL INDUSTRIES LTD., SUN PHARMACEUTICAL INDUSTRIES, INC. ( ...

Document INCYTE CORPORATION et al v. SUN PHARMACEUTICAL INDUSTRIES LTD. et al, 2:24-cv-06944, No. 1 (D.N.J. Jun. 11, 2024)
Complaint
Log in to see more
cite Cite Document

No. 56 NOTICE by All Plaintiffs of Name Change (Attachments: # 1 Amended Rule 7.1 Corporate Disclosure ...

Document TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC. et al v. DEVA HOLDING A.S., 2:24-cv-04404, No. 56 (D.N.J. Feb. 11, 2025)
Log in to see more
cite Cite Document
<< 1 2 3 4 5 6 7 8 ... >>